Sender Co & Partners Inc. Sells 170,525 Shares of Core Scientific, Inc. (NASDAQ:CORZ)

Sender Co & Partners Inc. decreased its position in Core Scientific, Inc. (NASDAQ:CORZ - Free Report) by 83.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 34,003 shares of the company's stock after selling 170,525 shares during the quarter. Sender Co & Partners Inc.'s holdings in Core Scientific were worth $478,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. Shay Capital LLC boosted its holdings in shares of Core Scientific by 6.7% during the fourth quarter. Shay Capital LLC now owns 80,000 shares of the company's stock valued at $1,124,000 after acquiring an additional 5,000 shares during the period. ProShare Advisors LLC increased its stake in Core Scientific by 52.1% in the 4th quarter. ProShare Advisors LLC now owns 51,261 shares of the company's stock worth $720,000 after purchasing an additional 17,557 shares in the last quarter. Panoramic Capital LLC purchased a new position in Core Scientific during the 4th quarter valued at about $1,644,000. Parsifal Capital Management LP grew its stake in Core Scientific by 3.7% during the 4th quarter. Parsifal Capital Management LP now owns 5,615,199 shares of the company's stock valued at $78,894,000 after acquiring an additional 202,374 shares in the last quarter. Finally, Man Group plc purchased a new position in Core Scientific during the 4th quarter valued at about $2,884,000.

Insiders Place Their Bets

In other news, Director Todd A. Becker sold 134,250 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $10.75, for a total value of $1,443,187.50. Following the completion of the sale, the director now directly owns 195,687 shares in the company, valued at approximately $2,103,635.25. This trade represents a 40.69% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Jordan Levy bought 62,500 shares of the stock in a transaction dated Thursday, March 6th. The stock was acquired at an average price of $8.01 per share, with a total value of $500,625.00. Following the completion of the purchase, the director now owns 306,887 shares of the company's stock, valued at $2,458,164.87. This represents a 25.57% increase in their position. The disclosure for this purchase can be found here. Corporate insiders own 1.40% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on CORZ. Cantor Fitzgerald reduced their price target on Core Scientific from $24.00 to $21.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Craig Hallum began coverage on Core Scientific in a report on Tuesday, January 21st. They set a "buy" rating and a $24.00 price target for the company. Keefe, Bruyette & Woods began coverage on Core Scientific in a report on Monday, January 27th. They set an "outperform" rating and a $22.00 price target for the company. Canaccord Genuity Group reiterated a "buy" rating and set a $17.00 price target on shares of Core Scientific in a report on Friday, May 9th. Finally, Oppenheimer assumed coverage on Core Scientific in a report on Wednesday, May 14th. They issued an "outperform" rating and a $15.00 target price for the company. Sixteen analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Buy" and a consensus target price of $18.75.

Core Scientific Stock Performance

Shares of CORZ traded up $0.07 during mid-day trading on Tuesday, hitting $10.92. The company's stock had a trading volume of 12,404,707 shares, compared to its average volume of 13,224,945. Core Scientific, Inc. has a one year low of $3.85 and a one year high of $18.63. The firm has a market capitalization of $3.25 billion, a PE ratio of -2.02 and a beta of 6.66. The stock's 50-day moving average is $8.16 and its two-hundred day moving average is $11.93.

Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported ($0.10) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.02. The firm had revenue of $79.53 million during the quarter, compared to analyst estimates of $92.04 million. During the same quarter in the previous year, the company posted $0.78 earnings per share. The business's revenue for the quarter was down 55.6% compared to the same quarter last year. Analysts expect that Core Scientific, Inc. will post 0.52 EPS for the current fiscal year.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.